Rolled Activators would refer to a theoretical group of compounds that target and enhance the activity of the rolled gene product, which is homologous to the mitogen-activated protein kinase (MAPK) in the fruit fly Drosophila melanogaster. The rolled gene encodes a serine/threonine-protein kinase involved in a variety of cellular processes, including the regulation of developmental pathways and the response to environmental stress. Activators of rolled would be expected to promote the kinase activity of its encoded protein, potentially by facilitating its phosphorylation state or by stabilizing the active conformation of the kinase domain. These activators could act by enhancing the interaction between rolled and its upstream activators or by preventing its deactivation by phosphatases. The result would be an elevated signaling cascade efficiency within the MAPK pathway, leading to a pronounced effect on the processes governed by rolled.
To investigate and characterize rolled activators, a multifaceted approach incorporating both in vitro and in vivo techniques would be employed. In vitro, kinase assays could be conducted using purified rolled protein to directly measure the impact of these activators on its kinase activity. This might be done by measuring the transfer of the gamma-phosphate from ATP to a substrate peptide or a relevant protein target, often detected through radiolabeled ATP or colorimetric readouts. Additionally, binding assays could help clarify how the activators interact with the rolled kinase domain, and protein conformation studies, perhaps through circular dichroism or fluorescence spectroscopy, could indicate conformational changes that enhance rolled's activity. In vivo, genetic studies in Drosophila could be used to assess the phenotypic outcomes of rolled activation, looking at specific developmental endpoints or stress responses that are known to depend on the MAPK pathway. Furthermore, the use of reporter gene constructs that respond to rolled activity could provide real-time insights into the spatial and temporal dynamics of rolled signaling within the organism. Through these experimental strategies, the molecular mechanisms by which rolled activators exert their effects could be elucidated.
製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMAはプロテインキナーゼCを活性化し、それがMAPK経路の活性化につながり、おそらくロール発現につながる。 | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
アニソマイシンはタンパク質合成阻害剤であるが、MAPK経路も活性化し、ロール発現を増加させる可能性がある。 | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126はMEKの阻害剤であるため、rollの発現をアップレギュレートする代償メカニズムにつながる可能性がある。 | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059はもう一つのMEK阻害剤であり、同様にロール発現の代償的なアップレギュレーションを引き起こす可能性がある。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
リチウムはグリコーゲン合成酵素キナーゼ-3(GSK-3)活性に影響を及ぼし、MAPK経路やロール発現に影響を及ぼす可能性がある。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
フォルスコリンはアデニル酸シクラーゼを活性化し、cAMPレベルを上昇させ、ロール発現に影響を及ぼす可能性がある。 | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
レスベラトロールは、MAPK経路を含む複数のシグナル伝達経路に影響を与え、ロール発現をアップレギュレートする可能性がある。 | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $106.00 $765.00 | 3 | |
ヒ素ナトリウムは酸化ストレスを誘発し、MAPK経路を活性化して、転写を促進する可能性がある。 | ||||||
D-Sorbitol | 50-70-4 | sc-203278A sc-203278 | 100 g 1 kg | $28.00 $68.00 | ||
ソルビトールは浸透圧ストレスを誘発し、ストレス活性化プロテインキナーゼを活性化し、発現をロールバックする可能性がある。 |